CNBC - Health
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
2 hours ago
CVS blows past estimates, hikes guidance as insurance unit continues to improve3 hours ago
Novo CEO defends economics of Wegovy pill as lower prices weigh on sales3 hours ago
Chipotle stock falls on potential link to salmonella outbreak in Minnesota20 hours ago
Novo Nordisk shares slide after guidance disappoints investors20 hours ago
P&G will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBC20 hours ago
Pfizer tops estimates, hikes low end of revenue guidance on non-Covid products22 hours ago
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance1 day ago
Michigan confirms first two deaths in cyclospora outbreak1 day ago
AstraZeneca in talks with Bristol Myers Squibb on $400B megadeal, FT reports1 day ago
Novo Nordisk shares dive after heart medicine fails trial in blow to pipeline2 days ago
New Medicaid work rules could leave rare disease patients uninsured5 days ago
AI stocks rebound, and why J&J's earnings guidance cut is not cause for concern5 days ago
Hims and Hers shares fall 10% as FTC sues company over data, billing practices6 days ago
Humana tops estimates, maintains profit outlook as medical costs stay in line6 days ago
Why shareholders are suing Novo Nordisk over next-generation weight-loss drug7 days ago
Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead7 days ago
Kentucky Gov. Beshear calls on Mitch McConnell to prove he can serve or resign7 days ago
McConnell still not cleared to go back to work as he recovers from fall: Doctors7 days ago
Consolidated food supply may be worsening cyclospora outbreaks, experts say8 days ago
FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business8 days ago
Here are 4 forces that drove a tough week for stocks10 days ago
CDC says massive cyclospora outbreak is now in nine states11 days ago
Cyclospora outbreak tests RFK Jr.'s promise to overhaul food system11 days ago
Eli Lilly says it will file for approval of next-generation obesity drug in 202713 days ago
Ozempic face? Botox boom boosted by 'sagging face' trend, Swiss firm says13 days ago
What Trump's generic drug tariffs could mean for patients, drugmakers and prices13 days ago
RFK Jr. says cyclospora outbreak is 'under control'14 days ago
Cardinal Health's latest deals won't move the needle overnight. They still matter.14 days ago
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising15 days ago
The FDA made a reversal on cyclosporiasis, but it still thinks iceberg lettuce is to blame15 days ago
What to know about testosterone replacement as U.S. military plans to test troops15 days ago
